[Federal Register Volume 79, Number 45 (Friday, March 7, 2014)]
[Notices]
[Pages 13053-13054]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-04970]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-14-14CL]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to [email protected]. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
An Investigation of Lung Health at an Indium-Tin Oxide Production
Facility--New--National Institute for Occupational Safety and Health
(NIOSH), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The mission of the National Institute for Occupational Safety and
Health (NIOSH) is to promote safety and health at work for all people
through research and prevention. The Occupational Safety and Health
Act, Public Law 91-596 (section 20[a][1]), authorizes NIOSH to conduct
research to advance the health and safety of workers. NIOSH is
proposing to conduct a study regarding the lung health of workers at an
indium-tin oxide production facility.
Indium-tin oxide (ITO) is a sintered material used in the
manufacture of devices such as liquid crystal displays, touch panels,
solar cells, and architectural glass. Indium lung disease is a novel,
potentially fatal industrial disease that has occurred in workers
making, using, or recycling ITO. This project aims to understand and
prevent this occupational lung disease by investigating the
relationship between exposure and lung health among current ITO
manufacturing workers.
CDC requests Office of Management and Budget (OMB) approval to
collect standardized information from current employees of the ITO
production facility through an informed consent document, an
interviewer-administered questionnaire, and a contact information form.
As part of the same project, employees will be offered the opportunity
to participate in medical testing and personal air sampling.
The questionnaire will collect contact information, demographic
information, respiratory symptoms and diagnoses, work history, and
cigarette smoking history. The questionnaire will allow NIOSH to report
individual medical test results to each participant and to analyze
aggregate data from the workforce to determine risk factors for
abnormal lung health indices derived from the medical test results. The
individual results will be used by employees and their personal
physicians to make medical decisions, such as whether to pursue
additional testing. The aggregate results will be used by NIOSH,
facility management, and employees in ongoing efforts to reduce
exposures and monitor key health indices.
For this study, we will recruit all current employees of the ITO
production facility. Participation is voluntary. We anticipate
approximately 100 study participants. Employees who wish to participate
in the questionnaire and medical testing will review and sign an
informed consent document. Employees who wish to participate in the
personal air sampling and would like to receive personal results will
complete a contact information form. Participants who wish to release
medical records to NIOSH or to have NIOSH release the results of our
medical testing to a personal physician will need to complete the
appropriate records release forms.
The questionnaire will be administered privately at the workplace
during normal working hours by trained NIOSH staff. Employees who are
not available at the workplace during the study will be offered the
opportunity to respond to the questionnaire at a later date by
telephone.
There are no costs to participants other than their time.
The total estimated burden for the one-time collection of data is
254 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Current ITO production facility Recruitment letter...... 100 1 5/60
employees.
Consent to participate 95 1 15/60
in a research study.
Authorization to 95 1 5/60
disclose health
information.
Indium facility 95 1 20/60
questionnaire.
Medical testing......... 95 1 100/60
Script for collection of 95 1 5/60
industrial hygiene
samples.
Personal air sampling 95 1 5/60
results contact
information form.
Exposure monitoring..... 95 1 5/60
----------------------------------------------------------------------------------------------------------------
[[Page 13054]]
Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-04970 Filed 3-6-14; 8:45 am]
BILLING CODE 4163-18-P